GlassScriptPhysician profile
Carmen Fernandez
NPI 1457319881
$1,111.43
in general payments reported to CMS, 2019-2025
14 companies · $26.57 in 2025
The $26.57 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $880 · 2020: $77.55 · 2021: $38.93 · 2023: $88.69 · 2025: $26.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $115.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $270.76 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $198.48 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $162.41 | 2019-2023 | |
| Novo Nordisk INC | $116.74 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $111.21 | 2019 | |
| Lilly USA, LLC | $41.29 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $40.54 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $40.37 | 2019 | |
| Glaxosmithkline, LLC. | $28.88 | 2019 | |
| Amgen INC. | $23.43 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $22.47 | 2019 | |
| Amryt Pharma Holdings LTD | $20.33 | 2020 | |
| Allergan, INC. | $19.17 | 2019 | |
| Medtronic, INC. | $15.35 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.